Abstract PO2-05-05: ELECTRA: An open-label, multicenter, phase 1b/2 study of elacestrant in combination with abemaciclib in patients with brain metastasis (mets) from estrogen receptor-positive (ER+), HER2-negative (HER2-) breast cancer (BC)
Year: 2024
Type: conference-abstract
Source: Cancer Research
Authors: Nuhad Ibrahim, Sung-Bae Kim, Nancy Lin, Ahmad Awada, Eva Ciruelos Gil, Giulia Tonini, Bartomeu Piza Vallespir, Kathy Puvana Theall, Erika Hamilton
Institutions: The University of Texas MD Anderson Cancer Center, Asan Medical Center, Harvard University, Dana-Farber Cancer Institute, Université Libre de Bruxelles, Institut Jules Bordet, Hospital Universitario 12 De Octubre, Menarini Group (Italy), Stemline Therapeutics (United States), Sarah Cannon
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4396599588